NeoGenomics promotes Warren Stone to President & COO; COO Melody Harris to depart in May

NEOGENOMICS INC

Warren Stone promoted from CCO to President & COO effective April 1, 2025; retains commercial duties and adds lab operations, data solutions, enterprise operations.
Melody Harris, current COO, will depart at end of May 2025; the COO position is eliminated.
Stone's base salary raised to $650,000, target bonus 70% of salary, annual equity target $3M; receives incremental $1M equity grant on April 1.
Incoming CEO Tony Zook says alignment of commercial and operations teams increases agility and supports growth strategy.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Melody Harris

Chief Operations Officer

NEO · NEOGENOMICS INC

Effective: 2025-04-01
Filed: March 18, 2025, 7:59 PM ET

Additionally, on March 18, 2024, the Company announced that the Chief Operations Officer position is being eliminated and as a result, Melody Harris, the current Chief Operations Officer, will no longer hold such role and will no longer be a named executive officer effective April 1, 2025.

Role change

Warren Stone

President & Chief Operating Officer

NEO · NEOGENOMICS INC

Effective: 2025-04-01
Filed: March 18, 2025, 7:59 PM ET

On March 18, 2025, NeoGenomics, Inc. (the "Company") announced the promotion of Warren Stone, the Company's current Chief Commercial Officer, to the position of President & Chief Operating Officer, effective April 1, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Melody Harris departed as Chief Operations Officer at NEOGENOMICS INC.

Action: departing
Role: Chief Operations Officer

Exact text from the filing

Additionally, on March 18, 2024, the Company announced that the Chief Operations Officer position is being eliminated and as a result, Melody Harris, the current Chief Operations Officer, will no longer hold such role and will no longer be a named executive officer effective April 1, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Warren Stone changed role as President & Chief Operating Officer at NEOGENOMICS INC.

Action: promoted
Role: President & Chief Operating Officer

Exact text from the filing

On March 18, 2025, NeoGenomics, Inc. (the "Company") announced the promotion of Warren Stone, the Company's current Chief Commercial Officer, to the position of President & Chief Operating Officer, effective April 1, 2025.

View on SEC.gov

NEOGENOMICS INC filing history →

Source: SEC EDGAR

accession 0001077183-25-000048

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.